Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Sales (2016 - 2025)

Aytu Biopharma (AYTU) has disclosed Return on Sales for 14 consecutive years, with 0.0% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 1.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, up 2.0% year-over-year, with the annual reading at 0.01% for FY2025, 6.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.0% at Aytu Biopharma, down from 0.0% in the prior quarter.
  • The five-year high for Return on Sales was 0.02% in Q3 2024, with the low at 2.2% in Q1 2022.
  • Average Return on Sales over 5 years is 0.31%, with a median of 0.06% recorded in 2023.
  • The sharpest move saw Return on Sales tumbled -212bps in 2022, then skyrocketed 189bps in 2023.
  • Over 5 years, Return on Sales stood at 0.5% in 2021, then skyrocketed by 49bps to 0.25% in 2022, then surged by 82bps to 0.04% in 2023, then soared by 117bps to 0.01% in 2024, then tumbled by -76bps to 0.0% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.0%, 0.0%, and 0.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.